Safety Study of Anti-Asthma Agent BMEC-1217B (Q61921470)

From Wikidata
Jump to navigation Jump to search
clinical trial
edit
Language Label Description Also known as
English
Safety Study of Anti-Asthma Agent BMEC-1217B
clinical trial

    Statements

    A Phase 1, Double-Blind, Randomized, Placebo-Controlled, Dose-Escalating Safety Study of BMEC-1217B, in Healthy Volunteers (English)
    0 references
    0 references
    0 references
    July 2008
    0 references
    32
    0 references
    20 year
    0 references
    40 year
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit